https://monaldi-archives.org/index.php/macd/issue/feed Monaldi Archives for Chest Disease 2019-09-18T23:52:36+02:00 Nadia Moscato nadia.moscato@pagepress.org Open Journal Systems <p><strong>Monaldi Archives for Chest Disease</strong> is an international scientific journal of the <em>Istituti Clinici Scientifici Maugeri</em>, Pavia, Italy, dedicated to the advancement of knowledge in all fields of cardiopulmonary medicine and rehabilitation. <!--It is published in two series: the “Cardiac Rehabilitation and Prevention Series” (volume, even numbers) which, since 2002, is the official journal of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiology (GICR-IACPR); and the “Pulmonary Medicine and Rehabilitation Series” (volume, odd numbers).--></p> <p><strong>Monaldi Archives for Chest Disease</strong> publishes original articles, new methodological approaches, reviews, opinions, editorials, position papers on all aspects of cardiac and pulmonary medicine and rehabilitation, and, in addition, provides a forum for the inter-exchange of information, experiences and views on all issues of the cardiology profession, including education. Accordingly, original contributions on nursing, exercise treatment, health psychology, occupational medicine, care of the elderly, health economics and other fields related to the treatment, management, rehabilitation and prevention of cardiac and respiratory disease are welcome.</p> <p><strong>Monaldi Archives for Chest Disease</strong> promotes excellence in the profession of cardiology and pneumology through its commitment to the publication of research, support to continuous education, and encouragement and dissemination of ‘best practice’.</p> <p>This journal does not apply charge for publication to Authors as it is supported by institutional funds.</p> https://monaldi-archives.org/index.php/macd/article/view/1101 Referral from vascular surgery to cardiovascular rehabilitation and related outcomes in patients with peripheral arterial disease: the THINKPAD-RELOADED survey 2019-09-18T23:52:36+02:00 Marco Ambrosetti marco.ambrosetti@icsmaugeri.it Pompilio Faggiano faggiano@numerica.it Cesare Greco c.greco1275@gmail.com Gian Francesco Mureddu mureddu.gianfra@gmail.com Pier Luigi Temporelli pierluigi.temporelli@icsmaugeri.it Roberto F.E. Pedretti roberto.pedretti@icsmaugeri.it <p>The utilization of cardiovascular rehabilitation (CR) programmes in patients with Lower Extremity Peripheral Artery Disease (LEPAD) is generally poor, with limited evidence of current policies for referral. The aim of the study was to evaluate, within a cohesive network of CR and vascular surgery facilities with facilitated referral process, the clinical characteristic of LEPAD patients referred to CR and related outcomes, as compared to patients not referred. The present is an observational prospective study of consecutive patients recruited at vascular surgery facilities. Out of 329 patients observed, the average referral rate to CR was 34% (28% and 39% in patients with and without recent peripheral revascularization, p&lt;0.05). LEPAD patients entering the CR programme were similar to those who did not according to sex, age, the vascular surgery setting of evaluation, and localization of arterial lesions. Patients with moderate intermittent claudication and patients with acute limb ischemia as index event were more represented among those who attended CR (41% <em>vs</em> 21% and 9% <em>vs</em> 2% respectively, p&lt;0.05). Patients referred to CR had five times more episodes of acute coronary syndrome and heart failure as complication of the index event. The cardiovascular risk profile (obesity 29.5% <em>vs</em> 11%, p&lt;0.05; hypercholesterolemia 80% <em>vs</em> 61%, p&lt;0.05) was much worse in LEPAD patients referred to CR, but conversely, they better achieved secondary prevention targets, particularly for blood pressure control (97% <em>vs</em> 57%, p&lt;0.05). All-cause 2-year mortality in the whole patients’ population was 6%. Patients entering the CR programme displayed less events (13.5% <em>vs</em> 37.7%, p&lt;0.05), mainly death (3.1% <em>vs</em> 11.3%, p&lt;0.05) and limb-related events (4.2% <em>vs</em> 15.2%, p&lt;0.05). The results of our study suggest that when a cohesive network of vascular surgery and CR facilities becomes available, the referral rate to rehabilitation may increase up to one third of eligible patients. Patients with higher comorbidity and cardiovascular risk seem to have priority in the referral process, nevertheless those with peripheral revascularization are still underestimated. Entering CR may ensure better cardiovascular risk profile and cardiovascular prognosis in LEPAD patients, and consequently the systematic adoption of this care model needs to be strongly recommended and facilitated.</p> 2019-09-18T13:19:22+02:00 ##submission.copyrightStatement## https://monaldi-archives.org/index.php/macd/article/view/1029 Depression and heart failure: an intricate relationship 2019-09-18T23:50:38+02:00 Gaetano Aloisi gaetano.aloisi@gmail.com Alberto Zucchelli gaetano.aloisi@gmail.com Bruno Aloisi gaetano.aloisi@gmail.com Giuseppe Romanelli gaetano.aloisi@gmail.com Alessandra Marengoni gaetano.aloisi@gmail.com <p>In patients with heart failure (HF), depression is common and associated with adverse outcomes such as reduced adherence to treatment, poor quality of life, increased hospitalizations and elevated mortality. Despite these adverse impacts, depression remain underdiagnosed in HF patients. We performed a target review of the literature to identify the association between HF and depression, to examine the mechanisms that link these two conditions and to identify instruments for an accurate diagnosis and treatment of depression in HF patients. Depression is associated with the development and progression of HF, including increased rates of mortality, mediated by behavioral and pathophysiological mechanisms. The overlap of symptoms between depression and HF often makes the diagnosis of depression difficult and late. Currently, specific guidelines for depression screening in HF patients are lacking, partly because evidences showing that depression screening improves cardiac outcomes are insufficient. European guidelines suggest the early use of instruments such as the Beck Depression Inventory (BDI) and the Geriatric Depression Scale (GDS), both characterized by accuracy and administration simplicity. There is limited evidence of pharmacological treatment and psychotherapy efficacy in patients with HF. However, cognitive-behavioral therapy has been shown to improve outcomes HF patients, and selective serotonin reuptake inhibitors appear safe in this cohort.</p> 2019-09-11T15:14:18+02:00 ##submission.copyrightStatement## https://monaldi-archives.org/index.php/macd/article/view/1074 Organizing pneumonia secondary to cetuximab in a patient with colorectal cancer 2019-09-18T23:50:39+02:00 Abdulaziz AlGhulayqah dr.3bdal3ziz@gmail.com Bader AlShamsan baderalshamsan@gmil.com Shouki Bazarbashi bazarbashi@gmail.com Shamayel Mohammed mobeireek@yahoo.com Abdullah Mobeireek mobeireek@yahoo.com <p>Organizing pneumonia (OP) may be idiopathic or secondary to a variety of causes including drugs. OP and other forms of pulmonary toxicity secondary to cetuximab, however, have been described rarely. It is paramount to recognize and differentiate OP from other common conditions that cancer patients are prone to such as infection and pulmonary embolism. A 69-year-old man with colorectal cancer received ten cycles of palliative chemotherapy [FOLFIRI (5-Fluorouracil, Leucovorin, Irinotecan) and cetuximab] with clinical and radiological response. He developed dyspnea following cycle 4, then 6 weeks later presented with cough, fever, tachypnea, hypoxia, bilateral crackles and diffuse pulmonary shadows. He was started on antibiotics but his condition deteriorated further. Cultures, including blood and bronchioalveolar lavage, grew no pathogens and molecular analysis and cytology for bacteria viruses were negative. Trans-bronchial biopsy was consistent with organizing pneumonia. Treatment with corticosteroids resulted in dramatic clinical and radiological resolution with normalization of gas exchange and pulmonary function. Corticosteroids were stopped and he was restarted on FOLFIRI and remained well with no relapse over a year of follow up. Although pulmonary toxicity secondary to cetuximab is uncommon, it is important to recognize, as it may be associated with poor prognosis. To the best of our knowledge, this is the first report of OP attributed to cetuximab with histopathological evidence.</p> 2019-09-11T15:12:00+02:00 ##submission.copyrightStatement## https://monaldi-archives.org/index.php/macd/article/view/1109 Radial pseudoaneurysm in elderly: a rare event with undefinied therapeutical approach. A case report and literature review 2019-09-18T23:50:40+02:00 Emanuele Gallinoro e.gallinoro@gmail.com Francesco Natale francesco.natale@unicampania.it Saverio D’Elia giovanni.cimmino@unicampania.it Paolo Golino paologolino@unicampania.it Giovanni Cimmino giovanni.cimmino@unicampania.it <p>Radial artery pseudoaneurysm (RAP) after cardiac catheterization in elderly patients is a rare complication. Clinical manifestations are pain, swelling and haematoma of the harm. The diagnosis is made through doppler ultrasonography, but the best therapeutical option is still matter of debate. Traditionally, surgical treatment has been considered the gold standard but new and less invasive strategies have been recently proposed: ultrasound-guided compression and local injection of thrombin. In this report we describe the unique case of an 84-year-old female patient who developed radial artery pseudoaneurysm after a failed radial artery access for cardiac catheterization. Finally, the pseudoaneurysm was successfully treated by surgical approach as several attempts of local compression failed. We aimed also at reviewing the treatment options of RAP in elderly patients (&gt;75 years old) and the safety/effectiveness reported in literature<em>.</em></p> 2019-09-10T11:56:42+02:00 ##submission.copyrightStatement##